Roche’s Lucentis Works to Treat Vision Loss from Diabetes

Roche Holding AG’s Lucentis works to treat a leading cause of blindness associated with diabetes, U.S. regulators said.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.